Top

Techniques in Coloproctology

Published in:

01-04-2021 | Rectal Cancer | Original Article

Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach

Authors: S. H. Song, G.-S. Choi, H. J. Kim, J. S. Park, S. Y. Park, S.-M. Lee, J. A. Choi, H. A. Seok

Published in: Techniques in Coloproctology | Issue 4/2021

Abstract

Background

The long-term outcomes of minimally invasive lateral pelvic lymph node dissection (LPND) are not completely known. The aim of this study was to compare long-term outcomes between robotic and laparoscopic LPND in low rectal cancer patients with suspected lymph node metastasis in the pelvic sidewall.

Methods

We retrospectively reviewed the records of all rectal cancer patients who had laparoscopic or robotic total mesorectal excision (TME) with LPND between March 2006 and June 2016. Stage IV patients were excluded. The outcomes of patients who had laparoscopic and robotic TME with LPND were compared.

Results

Twenty-nine patients had laparoscopic LPND and 70 had robotic LPND. No significant differences in patient characteristics were observed between the two groups. The urinary retention rate was lower in the robotic group than in the laparoscopic group (7.1% vs. 24.1%; p = 0.043). During a median follow-up of 44.3 months, the overall recurrence rates were 48.3% and 31.4% in the laparoscopic and robotic groups, respectively (p = 0.175). The 5-year disease-free survival rates were 50.4% and 67.0% in the laparoscopic and robotic groups, respectively (p = 0.227). The 5-year overall survival rates were 65.0% and 92.2% in the laparoscopic and robotic groups, respectively (p = 0.017).

Conclusions

Robotic TME with LPND is safe and feasible. In particular, it is associated with lower urinary retention. Robotic TME with LPND might yield a similar local recurrence rate and 5-year disease-free survival, but favorable long-term overall survival as compared to the laparoscopic approach. However, considering the retrospective nature and both major variables of TME and LPND involved together, this should be cautiously interpreted.

Available only for authorised users

Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T (2006) Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49:1663–1672. https://doi.org/10.1007/s10350-006-0714-zCrossRefPubMed

Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T (2005) Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92(6):756–763. https://doi.org/10.1002/bjs.4975CrossRefPubMed

Watanabe T, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y, Hamaguchi T, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kawano H, Kinugasa Y, Kokudo N, Murofushi K, Nakajima T, Oka S, Sakai Y, Tsuji A, Uehara K, Ueno H, Yamazaki K, Yoshida M, Yoshino T, Boku N, Fujimori T, Itabashi M, Koinuma N, Morita T, Nishimura G, Sakata Y, Shimada Y, Takahashi K, Tanaka S, Tsuruta O, Yamaguchi T, Yamaguchi N, Tanaka T, Kotake K, Sugihara K (2018) Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol 23(1):1–34. https://doi.org/10.1007/s10147-017-1101-6CrossRefPubMed

Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Sugihara K (2009) Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Dis Colon Rectum 52(4):567–576. https://doi.org/10.1007/DCR.0b013e3181a1d994CrossRefPubMed

Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee (2017) Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 28(suppl_4):iv22-iv40. https://doi.org/10.1093/annonc/mdx224

Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, Van De Velde CJH, Beets GL, Rutten HJT, Kusters M (2019) Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low ct3/4 rectal cancer. J Clin Oncol 37(1):33–43. https://doi.org/10.1200/JCO.18.00032CrossRefPubMed

Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K (2020) Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1):1–42. https://doi.org/10.1007/s10147-019-01485-z.Jun15,2019CrossRefPubMed

Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, Lim SB, Lee TG, Kim DY, Kim JS, Chang HJ, Lee HS, Kim SY, Jung KH, Hong YS, Kim JH, Sohn DK, Kim DH, Oh JH (2010) Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11(7):637–645. https://doi.org/10.1016/S1470-2045(10)70131-5CrossRefPubMed

van Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ, COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218. https://doi.org/10.1016/S1470-2045(13)70016-0CrossRefPubMed

10.

Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H (2015) Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314(13):1346–1355. https://doi.org/10.1001/jama.2015.10529CrossRefPubMedPubMedCentral

11.

Stevenson ARL, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J, ALaCaRT Investigators, (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314(13):1356–1363. https://doi.org/10.1001/jama.2015.12009CrossRefPubMed

12.

Park JS, Choi GS, Lim KH, Jang YS, Kim HJ, Park SY, Jun SH (2011) Laparoscopic extended lateral pelvic node dissection following total mesorectal excision for advanced rectal cancer: initial clinical experience. Surg Endosc 25(10):3322–3329. https://doi.org/10.1007/s00464-011-1719-9CrossRefPubMed

13.

Kim HJ, Choi GS, Park JS, Park SY, Lee HJ, Woo IT, Park IK (2018) Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach. Surg Endosc 32(5):2466–2473. https://doi.org/10.1007/s00464-017-5948-4CrossRefPubMed

14.

Kim HJ, Choi GS, Park JS, Park SY, Cho SH, Lee SJ, Kang BW, Kim JG (2017) Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer. Oncotarget 8(59):100724–100733. https://doi.org/10.18632/oncotarget.20121CrossRefPubMedPubMedCentral

15.

Choi GS, Kim HJ, Park JS, Park SY (2019) Minimally invasive approach for lateral pelvic node dissection: a standardization based on surgical anatomy. Dis Colon Rectum 62(12):1550. https://doi.org/10.1097/DCR.0000000000001476CrossRefPubMed

16.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213. https://doi.org/10.1097/01.sla.0000133083.54934.aeCrossRefPubMedPubMedCentral

17.

Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Pietro BP, Edlin R, Hulme C, Brown J (2017) Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer the rolarr randomized clinical trial. JAMA 318(16):1569–1580. https://doi.org/10.1001/jama.2017.7219CrossRefPubMedPubMedCentral

18.

Baek SJ, Kim CH, Cho MS, Bae SU, Hur H, Min BS, Baik SH, Lee KY, Kim NK (2015) Robotic surgery for rectal cancer can overcome difficulties associated with pelvic anatomy. Surg Endosc 29(6):1419–1424. https://doi.org/10.1007/s00464-014-3818-xCrossRefPubMed

19.

Kim MJ, Park SC, Park JW, Chang HJ, Kim DY, Nam BH, Sohn DK, Oh JH (2018) Robot-assisted versus laparoscopic surgery for rectal cancer: a phase II open label prospective randomized controlled trial. Ann Surg 267(2):243–251. https://doi.org/10.1097/SLA.0000000000002321CrossRefPubMed

20.

Park JA, Choi GS, Park JS, Park SY (2012) Initial clinical experience with robotic lateral pelvic lymph node dissection for advanced rectal cancer. J Korean Soc Coloproctol 28(5):265–270. https://doi.org/10.3393/jksc.2012.28.5.265CrossRefPubMedPubMedCentral

21.

Lanfranco AR, Castellanos AE, Desai JP, Meyers WC (2004) Robotic surgery: a current perspective. Ann Surg 239(1):14–21. https://doi.org/10.1097/01.sla.0000103020.19595.7dCrossRefPubMedPubMedCentral

22.

Luca F, Valvo M, Ghezzi TL, Zuccaro M, Cenciarelli S, Trovato C, Sonzogni A, Biffi R (2013) Impact of robotic surgery on sexual and urinary functions after fully robotic nerve-sparing total mesorectal excision for rectal cancer. Ann Surg 257(4):672–678. https://doi.org/10.1097/SLA.0b013e318269d03bCrossRefPubMed

23.

Kim J, Baek SJ, Kang DW, Roh YE, Lee JW, Kwak HD, Kwak JM, Kim SH (2017) Robotic resection is a good prognostic factor in rectal cancer compared with laparoscopic resection: long-term survival analysis using propensity score matching. Dis Colon Rectum 60(3):266–273. https://doi.org/10.1097/DCR.0000000000000770CrossRefPubMed

24.

Liberale G, Bohlok A, Bormans A, Bouazza F, Galdon MG, El Nakadi I, Bourgeois P, Donckier V (2018) Indocyanine green fluorescence imaging for sentinel lymph node detection in colorectal cancer: a systematic review. Eur J Surg Oncol 44(9):1301–1306. https://doi.org/10.1016/j.ejso.2018.05.034CrossRefPubMed

25.

Nishigori N, Koyama F, Nakagawa T, Nakamura S, Ueda T, Inoue T, Kawasaki K, Obara S, Nakamoto T, Fujii H, Nakajima Y (2016) Visualization of lymph/blood flow in laparoscopic colorectal cancer surgery by ICG fluorescence imaging (Lap-IGFI). Ann Surg Oncol 23(Suppl2):S266–S274. https://doi.org/10.1245/s10434-015-4509-0CrossRefPubMed

26.

Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Tekkis P, Pedersen BG, Gudgeon M, Heald B, Brown G, MERCURY II Study Group (2016) Prospective validation of low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model : the MERCURY II Study. Ann Surg 263(4):751–760. https://doi.org/10.1097/SLA.0000000000001193CrossRefPubMed

27.

Yamaguchi T, Kinugasa Y, Shiomi A, Kagawa H, Yamakawa Y, Furutani A, Manabe S, Yamaoka Y, Hino H (2018) Oncological outcomes of robotic-assisted laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer. Surg Endosc 32(11):4498–4505. https://doi.org/10.1007/s00464-018-6197-xCrossRefPubMed

28.

Yamaguchi T, Kinugasa Y, Shiomi A, Tomioka H, Kagawa H (2016) Robotic-assisted laparoscopic versus open lateral lymph node dissection for advanced lower rectal cancer. Surg Endosc 30(2):721–728. https://doi.org/10.1007/s00464-015-4266-yCrossRefPubMed

29.

Yamaguchi T, Konishi T, Kinugasa Y, Yamamoto S, Akiyoshi T, Okamura R, Ito M, Nishimura Y, Shiozawa M, Yamaguchi S, Hida K, Sakai Y, Watanabe M (2017) Laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer: a subgroup analysis of a large multicenter cohort study in Japan. Dis Colon Rectum 60(9):954–964. https://doi.org/10.1097/DCR.0000000000000843CrossRefPubMed

30.

Kagawa H, Kinugasa Y, Shiomi A, Yamaguchi T, Tsukamoto S, Tomioka H, Yamakawa Y, Sato S (2015) Robotic-assisted lateral lymph node dissection for lower rectal cancer: short-term outcomes in 50 consecutive patients. Surg Endosc 29(4):995–1000. https://doi.org/10.1007/s00464-014-3760-yCrossRefPubMed

31.

Wichmann MW, Müller C, Meyer G, Strauss T, Hornung HM, Lau-Werner U, Angele MK, Schildberg FW (2002) Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 137(2):206–221. https://doi.org/10.1001/archsurg.137.2.206CrossRefPubMed

32.

Matsuoka N, Moriya Y, Akasu T, Fujita S (2001) Long-term outcome of urinary function after extended lymphadenectomy in patients with distal rectal cancer. Eur J Surg Oncol 27(2):165–169. https://doi.org/10.1053/ejso.2000.1064CrossRefPubMed

33.

Çöl C, Hasdemir O, Yalcin E, Guzel H, Tunc G, Bilgen K, Kucukpinar T (2005) The assessment of urinary function following extended lymph node dissection for colorectal cancer. Eur J Surg Oncol 31(3):237–241. https://doi.org/10.1016/j.ejso.2004.11.008CrossRefPubMed

34.

Park BK, Lee SJ, Hur BY, Kim MJ, Park SC, Chang HJ, Kim DY, Oh JH (2018) Feasibility of selective lateral node dissection based on magnetic resonance imaging in rectal cancer after preoperative chemoradiotherapy. J Surg Res 232:227–233. https://doi.org/10.1016/j.jss.2018.05.047CrossRefPubMed

35.

Furuhata T, Okita K, Nishidate T, Ito T, Yamaguchi H, Ueki T, Akizuki E, Meguro M, Ogawa T, Kukita K, Kimura Y, Mizuguchi T, Hirata K (2015) Clinical feasibility of laparoscopic lateral pelvic lymph node dissection following total mesorectal excision for advanced rectal cancer. Surg Today 45(3):310–314. https://doi.org/10.1007/s00595-014-0906-4CrossRefPubMed

36.

Akasu T, Sugihara K, Moriya Y (2009) Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer. Ann Surg Oncol 16(10):2779–2786. https://doi.org/10.1245/s10434-009-0546-xCrossRefPubMed

Title: Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach
Authors: S. H. Song
G.-S. Choi
H. J. Kim
J. S. Park
S. Y. Park
S.-M. Lee
J. A. Choi
H. A. Seok
Publication date: 01-04-2021
Publisher: Springer International Publishing
Keywords: Rectal Cancer
Laparoscopy
Rectal Cancer
Published in: Techniques in Coloproctology / Issue 4/2021
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI: https://doi.org/10.1007/s10151-020-02383-7

At a glance: The STEP trials

Springer Medicine

Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2021

Oncological outcomes and stoma-free survival following TaTME, a prospective cohort study

Big data papers and COVID-19: a “false friend” for academic surgeons

The management of adult appendicitis during the COVID-19 pandemic: an interim analysis of a UK cohort study

Simple fistula-in-ano: is it all simple? A systematic review

Mediterranean Society of Coloproctology Web Masterclass

Redo-laparoscopy in the management of complications after laparoscopic colorectal surgery: a systematic review and meta-analysis of surgical outcomes